Anocca is a biotechnology company that develops immunotherapies that leverage the immune system. It is focused on establishing a technology platform for analysis of T-cell biology to unlock the therapeutic potential of T-cell immunity. The company provides technologies to develop a range of therapeutic and prophylactic products in oncology, infectious disease, and autoimmunity.